Journal of Pharmaceutical and Biomedical Sciences

Login
Select Language
Subscription Login to verify subscription
Give a gift subscription
Article Tools
Print this article
Indexing metadata
How to cite item
Finding References
Review policy
Email this article (Login required)
Email the author(Login required)
Post a Comment (Login required)

The Protective Effect of Maluodan against Chronic Gastritis

Cai-Yun Jiang, Ji-Wei Huang, Yong-Ming Zhang, Zhu-Feng Wu

Abstract


Objective To explore the protective effect of the Maluodan Honey Pill (MHP) to chronic gastritis.
Methods The effects of gastric emptying and intestinal propulsion effects were observed by charcoal method. The ligation of pylorus was applied to investigate the effect of acid suppression.

Results During gastric emptying and intestinal propulsion experiments, the MHP groups (7 mg/kg/d or 3.5 mg/kg/d) had significant difference compared with the blank control group (P < 0.01). The gastric residual rate was decreased significantly
in MHP-H and MHP-L groups, while the intestinal residual rate was increased significantly. Compared with the blank control group, the value of pH on gastric juice significantly increased in MHP groups (P < 0.01). The total acidity of gastric juice significantly decreased in MHP group (7 mg/kg/d or 3.5 mg/kg/d) compared with the
blank control group (P < 0.01).

Conclusion The protective effect of MHP to chronic gastritis was performed via promoting of gastric emptying, intestinal propulsion and acid suppression.


Keywords


Maluodan Honey Pill (MHP), acid suppression, gastric emptying, intestinal propulsion

Full Text:

References


Yu Z, Wang G, Chen GY, Chang J, Zhang Y, Zhang RM. Muoluodan concentrated pill in treatment of chronic atrophic gastritis (the stomach-yin of deficiency and stagnated blood of stomach meridian): a prospective,

randomized, controlled trial. West China Med J (Chin). 2007;22:287–289.

Guo XJ. The curative effect observation on 200 cases of intetinal metaplasia of atrophic gastritis treated with Moluo Pills.J Beijing Univ Tradit Chin Med (Chin). 1997;17:33–35.

Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631–636.

Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis.2008;40:650–658.

Li EF, Mei JQ, Su TC, Miu YX. Regulating function of Moluodan on the gastric electrogram of chronic gastric diseases. Chin Tradit Patent Med (Chin). 1992;14:24–25.

Sipponen P, Price AB. The Sydney System for classification of gastritis 20 years ago. J Gastroenterol Hepatol. 2011;26:S31–S34.

Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut. 1999;45:784–790.

Correa P. Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol.1985;12:2–10.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.